20% Salicylic Acid Peel
Natural health product licensed in Canada
- Other names
- Alumier MD 20% Salicylic Acid Peel, Alumier MD BHA 20, Alumier MD BHA 20 Peel, BHA 20, BHA 20 Peel
- Licence holder
- Alumier Europe Ltd.
- NPN or DIN-HM
- 80072016
- Status
- Active licence
- Licence date
- 15 August 2016
- Revision date
- 24 September 2024
- Form
- Liquide
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-hydroxybenzoïque Source : Acide salicylique | 20 % |
Non-medicinal ingredients
Propanediol, SD alcool 40-B, Glycyrrhétinate de stéaryle, Dimethyl isosorbide, Hydroxyde de sodium, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Contributes to reduce the signs of chronic photo aging, by helping skin renewal. Helps to correct skin discoloration, by renewing the surface of the skin. For the treatment/management of acne. Helps treat acne pimples (Optional: "and allow skin to heal"). Dries and helps clear up acne pimples (Optional: "and allow skin to heal"). Reduces the number and/or severity of acne pimples (Optional: "and allow skin to heal"). Penetrates pores to help control (reduce) acne pimples. Helps keep skin clear of new acne pimples. Helps prevent new acne pimples from forming.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use on inflamed, irritated, reddened or broken skin. Not for use on individuals who are pregnant or breastfeeding, have diabetes, vitiligo, poor blood circulation, a herpetic breakout, open wounds, suspicious lesions, severely dry skin, currently suffer from any type of infection, are sensitive to aspirin/salicylic acid, have received recent chemotherapy or radiation therapy, used isotretinoin in the past 12 months or are taking photosensitizing medication.
- Effets indésirables connus
Some people may experience a burning sensation, dermatitis, swelling, or blisters.
- Précautions et mises en garde
Use only as directed. For Professional Use Only. Not for Retail Sale. For external use only. Keep out of reach of children. Patient should be explained the risks associated with this product prior to administration. Test product on a small area of the patient's skin, before applying to the whole area to be treated. If application causes severe discomfort or irritation, wash the area immediately with cold water and discontinue use. If irritation persists, consult a health care practitioner. If a severe reaction occurs (e.g. chemical burn, hives/blistering, swelling of eyes/mouth, blistering or difficulty breathing), seek immediate medical attention. Avoid contact with eyes and mucous membranes; if contact and irritation occur, rinse thoroughly with water. If swallowed, get medical help or contact a poison control centre immediately. This product may increase skin's sensitivity to the sun and particularly the possibility of sunburn. Please limit exposure to the sun and artificial UV light and apply a sunburn protectant while using this product and for a week afterwards. Avoid sport, swimming or the sauna for two days post treatment. Do not participate in laser or Intense Pulsed Light (IPL) facial treatments for 14 days post treatment. Using topical acne products or other chemical peels at the same time or immediately following use of this product may increase dryness or irritation of the skin. Only one product should be used, unless directed by a health care practitioner. Use caution if the patient suffers from immunosuppression, is taking oral contraceptives or tetracycline, has a recent history of medical or cosmetic treatment/procedure (e.g. laser therapy, surgical procedures, cosmetic filler, microdermabrasion,etc.), smoking, herpes simplex, dermatitis, psoriasis, or any other inflammatory condition in the skin area to be treated (as these may have an impact on wound healing).
Source
Official Health Canada record, licence 80072016
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging